This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (4)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

GEORGE H. KOSTANT, M.D.; SIMEON E. LANDY, M.D.; LOUISE C. KELCEC, M.T.

Arch Dermatol. 1961;84(2):310-312.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The purpose of this paper is to document our experience with treponemal testing since 1955 in a series of 1,064 clinically evaluated patients, and to discuss the patterns of seroreactivity after therapy in the various stages of syphilitic infection. We have been fortunate in being able to serologically evaluate certain cases for as long as 25 to 30 years after treatment.

The tests used in this study consist of specific treponemal procedures as well as a battery of standard serologic tests for syphilis. The treponemal procedures employed were the Treponema pallidum complement-fixation¹ (TPCF) test, the Reiter protein complement-fixation² (RPCF) test, and the Treponema pallidum immobilization (TPI) test. All of the serums studied were subjected to the TPCF and RPCF tests in our laboratory. A small number of serums were tested with the TPI test which was performed by Dr. James N. Miller of the University of California Medical . . . [Full Text PDF of this Article]

Author Affiliations
NEW YORK

From the Department of Dermatology and Syphilology of the New York University Post-Graduate Medical School (Dr. Marion B. Sulzberger, Chairman) and the Skin and Cancer Unit of the New York University Hospital.

Footnotes
Submitted for publication March 8, 1961.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?